Transanal Excision of Rectal Tumors



Transanal Excision of Rectal Tumors


Ryan M. Thomas

Barry Feig





PATIENT HISTORY AND PHYSICAL FINDINGS



  • Not all patients are candidates for TAE of rectal tumors and many factors may prove to be a contraindication to such treatment. The surgeon must take into account physiologic, anatomic, and pathologic factors in order to deem a patient an appropriate candidate for TAE of a benign or malignant rectal tumor (Table 1).


  • A full history must be performed with special focus on any changes in bowel habits including stool caliber, the presence of melena or hematochezia, personal or family history of colorectal cancer, and the use of any antiplatelet or anticoagulant medications in preparation for surgical excision.


  • Physiologic factors and patient desires may make TAE a viable option, namely in patients who physiologically cannot tolerate an extensive transabdominal resection or have a short life expectancy because of metastatic disease yet have a bleeding tumor in need of palliation. In addition, some patients may not desire an abdominoperineal resection and resultant permanent colostomy or the possibility of sexual dysfunction. Given appropriate physical and pathologic criteria, these patients may be appropriate candidates for TAE as well.


  • A thorough physical examination must be performed with special focus on rectal tone, location of the rectal tumor, distance of the tumor from the anal verge, and mobility/fixation of the tumor to underlying structures. These physical factors are critical to determine the feasibility of resection as the criteria for resection demands that the lesion:



    • Be within 8 to 10 cm of the anal verge in order to technically reach the lesion


    • Must be mobile and not fixed to underlying tissue


    • Must involve less than 30% of the circumference of the rectal wall on endoscopic evaluation, as anything greater risks nodal involvement or narrowing the rectal lumen after excision is performed.


  • Often, patients are referred for TAE of a rectal tumor after having undergone endoscopic evaluation that diagnosed a malignant mass or a benign mass not amenable to endoscopic resection.


  • Established pathologic criteria for TAE of a malignant lesion include T1 lesions, no evidence of lymphovascular invasion (LVI) or perineural invasion (PNI), moderately to well-differentiated tumors, or an endoscopically removed polyp with indeterminate pathology.


IMAGING AND OTHER DIAGNOSTIC STUDIES



  • Endoscopy plays an essential role in the management of midto low rectal lesions in patients who may be candidates for TAE. Endoscopy defines the anatomy of the lesion and special attention should be made to the anatomic location, as this will affect surgical positioning. The tumor diameter, location from the anal verge, and degree of circumferential involvement are noted as they dictate the appropriateness of TAE as well.


  • Assuming that a malignant lesion is technically resectable via a transanal approach, one must ensure that the lesion is a T1 stage and without nodal involvement. The transanal approach for rectal tumors has garnered support because of the decreased morbidity compared with a transabdominal approach but lymph node metastasis has been reported in 10% to 18% of T1 lesions.


  • Imaging therefore plays an essential role in the preoperative planning for patients considered candidates for TAE of rectal tumors. In the case of malignancy, staging imaging should include the following:



    • A chest x-ray and computed tomography (CT) of the abdomen and pelvis to assess for metastatic disease


    • Critical to the determination of the local resectability of a rectal lesion is the assessment of the T stage and N stage of the tumor. The accuracy of determining the depth of invasion by CT scan, magnetic resonance imaging (MRI), and endoscopic rectal ultrasound (ERUS) is 73%, 82%, and 87%, respectively. Nodal metastases are accurately assessed by CT scan, MRI, and ERUS in 66%, 74%, and 74% of cases, respectively. The use of endorectal coils during MRI has been found to be equivalent to ERUS for T stage determination but superior in terms of nodal status.








      Table 1: Criteria for Transanal Excision of Rectal Tumors











      Patient Factors


      Anatomic Factors


      Pathologic Factors




      • Comorbidities that preclude transabdominal resection



      • Short life expectancy in need of surgical palliation



      • Refusal of abdominoperineal resection and resultant permanent colostomy




      • Lesion ≤8-10 cm from the anal verge



      • Lesion involves ≤30% of rectal circumference



      • Lesion ≤3cm in diameter



      • Mobile and not fixed to underlying tissue



      • Negative margins achievable depending on pathology of primary lesion (0.3-1 cm)




      • Moderately or well-differentiated tumor



      • T1 tumor



      • No lymphovascular or perineural invasion



      • Indeterminate pathology on polypectomy



      • No evidence of lymphadenopathy on preoperative imaging




  • Any biopsies that are performed of the rectal tumor prior to definitive excision should be re-reviewed to confirm the tumor depth of invasion, differentiation, and the presence of LVI or PNI.


SURGICAL MANAGEMENT


Preoperative Planning



  • In most cases, patients should be instructed to discontinue anticoagulation and antiplatelet medications 7 to 10 days prior to the planned procedure if medically feasible.


  • A specific bowel preparation does not have to be performed except that the patient should self-administer a sodium phosphate enema the evening prior to the procedure in order to evacuate the rectal vault.


Patient Positioning



  • Positioning of the individual depends on the anatomic location of the rectal tumor to be excised, which should be determined on preoperative physical examination and endoscopy.


  • Because it is technically easier to visualize and resect rectal tumors when they are located closer to the operating room (OR) table, patients with a rectal tumor along the posterior rectal wall should be positioned in high lithotomy such that their coccyx can be easily palpated (FIG 1). In contrast, patients with lesions located along the anterior rectal wall should be placed in the prone jackknife position.


  • For patients placed in the prone position, heavy tape should be applied to the buttocks so that they can be retracted laterally and secured to the OR table. A 2-in-wide tape should be used and secured to the buttocks with benzoin ointment to prevent the tape from slipping during the procedure.


  • Once in position with pressure points appropriately padded, a digital rectal exam is performed to confirm tumor location and the rectum is irrigated with saline until all solid material has been removed. The perineum is then prepped with Betadine and appropriately draped.






FIG 1 • Patient positioning. For posterior lesions, the patient is placed on a high lithotomy position. It is important that the coccyx can be palpated, which ensures that they are low enough on the bed and adequate exposure to the lesion can be obtained.

Jul 24, 2016 | Posted by in GENERAL SURGERY | Comments Off on Transanal Excision of Rectal Tumors

Full access? Get Clinical Tree

Get Clinical Tree app for offline access